About AVT23 AVT23 is a monoclonal antibody and proposed biosimilar to Xolair ® (omalizumab). AVT23 is an investigational compound and has not received regulatory approval in any country. Biosimilarity ...
Marr, decided to open a South European-inspired wine bar in Oceanside, they didn’t offer ideas or pictures to the architect they hired to create the interior design. Instead, they sent over a chapter ...
The European Commission opened formal proceedings Wednesday under the Digital Services Act against the Chinese-owned Temu e-commerce platform for allegedly selling illegal products and for having an ...